Hexagon Capital Partners’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-381
| Closed | -$8.38K | – | 828 |
|
|
2025
Q1 | $8.38K | Hold |
381
| – | – | ﹤0.01% | 1025 |
|
|
2024
Q4 | $8.64K | Sell |
381
-85
| -18% | -$1.93K | ﹤0.01% | 1055 |
|
|
2024
Q3 | $8.47K | Sell |
466
-22
| -5% | -$400 | ﹤0.01% | 965 |
|
|
2024
Q2 | $14.2K | Sell |
488
-452
| -48% | -$13.2K | ﹤0.01% | 777 |
|
|
2024
Q1 | $33.3K | Buy |
940
+270
| +40% | +$9.57K | 0.01% | 524 |
|
|
2023
Q4 | $29.2K | Buy |
670
+370
| +123% | +$16.1K | 0.01% | 533 |
|
|
2023
Q3 | $11.5K | Buy |
300
+257
| +598% | +$9.82K | ﹤0.01% | 708 |
|
|
2023
Q2 | $1.77K | Sell |
43
-102
| -70% | -$4.2K | ﹤0.01% | 1100 |
|
|
2023
Q1 | $8.32K | Sell |
145
-137
| -49% | -$7.87K | ﹤0.01% | 772 |
|
|
2022
Q4 | $15.8K | Buy |
282
+56
| +25% | +$3.14K | ﹤0.01% | 606 |
|
|
2022
Q3 | $10K | Buy |
+226
| New | +$10K | ﹤0.01% | 772 |
|